The effect of switching basal insulin regimen to dulaglutide on efficacy and safety in Japanese patients with type 2 diabetes mellitus

The effect of switching basal insulin regimen to dulaglutide on efficacy and safety in Japanese patients with type 2 diabetes mellitus - The effect of switching basal insulin regimen to dulaglutide on efficacy and safety in Japanese patients with type 2 diabetes mellitus

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023914

Enrollment

Registered

2016-10-01

Start date

2016-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus

Interventions

We measure continuous glucose monitoring when switching basal insulin to dulaglutide. We measure the QOL of DTSQ at baseline of therapy with basal insulin and at after 24 weeks of therapy with dulaglu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The inclusion criteria were age => 20 years, diagnosis of type 2 diabetes, treatment with basal insulin for at least 24 weeks before entry into this study, and less than 1.0% HbAic change during the 24 weeks before entry into this study

Exclusion criteria

Exclusion criteria: 1,Type 1 diabetes mellitus 2,Any patient who could not understand the device of ATEOS and DTSQ questionnaire 3,Any other condition which the attending physician feels would interfere with trial participation

Design outcomes

Primary

Measure	Time frame
Change of continuous glucose monitoring when switching from basal insulin to dulaglutide	—

Secondary

Measure	Time frame
HbA1c and body waight after 24 weeks,QOL wtih DTSQ,occurrence of hypoglycemia	—

Countries

Japan

Contacts

Public ContactMohiriho Okada

Japan Community Healthcare Organization Kanazawa Hospital Department of Pharmacy

okada-knz@umin.ac.jp076-252-2200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026